GLP-1 Medications for Hypothyroidism
Hypothyroidism (underactive thyroid) slows metabolism and makes weight loss significantly more difficult. GLP-1 medications provide metabolic support independent of thyroid function, helping hypothyroid patients achieve weight loss that was previously very difficult. Hypothyroidism affects approximately 5% of the US population with mild hypothyroidism far more common, and GLP-1 medications offer a clinically proven treatment option.
Prevalence
approximately 5% of the US population with mild hypothyroidism far more common
Recommended Medications
2
Treatment Type
GLP-1 Agonist
How GLP-1 Medications Help with Hypothyroidism
GLP-1 medications provide metabolic support independent of thyroid function, helping hypothyroid patients achieve weight loss that was previously very difficult. For patients with hypothyroidism, GLP-1 medications address the underlying metabolic dysfunction that makes weight management difficult. Clinical trials have consistently shown that GLP-1 treatment produces significant improvements in both weight and condition-specific outcomes.
Recommended GLP-1 Medications for Hypothyroidism
Based on clinical evidence, the following GLP-1 medications are recommended for patients with hypothyroidism:
Semaglutide
Wegovy / Ozempic
Tirzepatide
Zepbound / Mounjaro
Detailed Medication Guides for Hypothyroidism
Hypothyroidism & GLP-1 FAQ
Can GLP-1 medications help with hypothyroidism?
Yes. GLP-1 medications provide metabolic support independent of thyroid function, helping hypothyroid patients achieve weight loss that was previously very difficult. Clinical evidence supports the use of GLP-1 medications like semaglutide and tirzepatide for patients with hypothyroidism.
Which GLP-1 medication is best for hypothyroidism?
Semaglutide is often the first-line recommendation for hypothyroidism due to its strong clinical evidence. Your provider will evaluate your specific situation to determine the best option.
How much weight can I lose with GLP-1 if I have hypothyroidism?
Weight loss results are generally comparable to clinical trial averages (15-22% of body weight), though individual results vary based on the severity of hypothyroidism and other health factors.
How prevalent is hypothyroidism?
Hypothyroidism affects approximately 5% of the US population with mild hypothyroidism far more common. GLP-1 medications represent a significant treatment advancement for patients dealing with this condition alongside excess weight.